Global Health Supply Chain Program ($10.5 Billion)
Download
Report
Transcript Global Health Supply Chain Program ($10.5 Billion)
USAID Update 2014
Bureau for Global Health
Christine Malati, PharmD
Anthony Boni
Lisa Ludeman, MSPH
December 16, 2014
1
Outline
• Structure of the Global Health Supply
Chain Program
• Updates on PQM and SIAPS
2
Global Health Supply Chain Program ($10.5 Billion)
Single-Award Procurement
& Technical Assistance IDIQ
($9.5b)
With the Following Task Orders:
1. Family Planning
2. HIV/AIDS
3. Malaria
4. MCH
HIV RTK
Procurement
IDIQ
($300m)
Small
Business Set
Aside
Multiple-Award
Technical Assistance
IDIQ
($500m)
Up To Four Awards,
Including one Small
Business Set Aside
Quality Assurance Contract ($123m)
Business Intelligence and Analytics ($20m) GSA Contract
Supply
Chain
Innovation
& Research
Annual
Program
Statement
($40m)
# of
Agreements
TBD
Single-Award Procurement
& Technical Assistance IDIQ
• 5-year single-award IDIQ
– 4 task orders (HIV, malaria, family planning and
reproductive health, maternal and child health)
• Global Commodity Procurement and
Logistics
• Systems strengthening
• Global collaboration
4
•
•
•
•
Five year single award IDIQ
Procurement of RTKs
Logistics
Collaboration within the GHSCP and with
other international stakeholders
5
Quality Assurance Award
• Goal: Establish and implement a
comprehensive QAP for USAID that
provides global technical leadership
regarding quality issues
1 Quality Assurance Program
2 Quality Control Strategy
3 Technical Leadership
4 Global Collaboration
6
Multiple Award Technical
Assistance IDIQ
• Goal: Improve the long-term availability of
health commodities in public and private
services
• Objective 1: Systems Strengthening
Technical Assistance – Strengthen incountry supply systems
• Objective 2: Global Collaboration –
strategic engagement to improve the longterm availability of health commodities
7
Multiple Supply Chain Assistance
Cooperative Agreements and/or Grants
Overall objective: Support research on a focused set of
health supply chain systems and related commodity security
issues in low and middle income countries.
• Objective 1. Improve health supply chain systems through
transformative changes that use industry best practice;
• Objective 2. Improve the quantity, reliability, and efficiency
of financing for health commodities and supply chain
systems;
• Objective 3. Improve governance and accountability for
commodity security.
8
• $20m Contract
• Purpose: to build and maintain as a Software as a
Service (SaaS) USAID GH Business Intelligence and
Analytics (BI&A) platform and provide technical services
for and on behalf of USAID GH Bureau and the supply
chain business initiatives.
• Program Management
• Data warehouse
• Data mapping
• Data migration
• Knowledge Management Database
9
SIAPS: Recent Accomplishments
• Advancing a framework and metrics to measure pharmaceutical
systems strengthening
• “Enhancing Health Outcomes for Chronic Diseases in Resource
Limited Settings by Improving the Use of Medicines: The Role of
Pharmaceutical Care”
• Improving understanding of the vital role medicines play in Universal
Health Coverage
• Development of an accreditation framework for the establishment of
national pharmaceutical continuous education programs in LMICs.
• SIAPS West Africa Regional Project launches an Early Warning
System (EWS) for HIV/AIDS commodities
• Improving governance capacity for more transparent and accountable
pharmaceutical systems
• Applying knowledge management approaches to improve
pharmaceutical management through collaboration with WHO
PQM: Recent Accomplishments
• Promoting the Quality of Medicines Program extended to September 2019
• Two PQM-supported manufacturers in China are the first to be
prequalified for Capreomycin Active Pharmaceutical Ingredient (API).
• PQM supported the first generic producer of Capreomycin to achieve
WHO prequalification, thereby helping to reduce the cost of this medicine.
• PQM supported the only major producer of Kanamycin to obtain GMP
compliance status from the WHO Prequalification Program for the nonsterilized API of Kanamycin.
• Ghana Food and Drug Authority QC lab receives ISO 17025 accreditation
for compendial tests used to assess the quality of essential medicines.
• With PQM support, the Ethiopian drug regulatory authority (FMHACA)
laboratory became the first medical device laboratory in Africa to achieve
ISO 17025 accreditation ((testing of male condoms).
• Monograph developed (specifications, QC tests to perform, and methods)
for Dihydroartemisinin-piperaquine phosphate tablets (DHAP), thereby
enabling testing of this important FDC antimalarial.
USAID Update 2014
Bureau for Global Health
Christine Malati, PharmD
Anthony Boni
Lisa Ludeman, MSPH
December 16, 2014
12